Keros Therapeutics (KROS) P/E (2020 - 2026)
Keros Therapeutics (KROS) P/E from Jun 30, 2020 to Jul 21, 2026. The TTM Keros Therapeutics (KROS) P/E is -3.17. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Keros Therapeutics (KROS)
| Year | P/E | Change |
|---|---|---|
| 2026 | -3.17 | -123.72% |
| 2025 | 13.36 | -516.00% |
| 2024 | -3.21 | -60.56% |
| 2023 | -8.14 | -43.80% |
| 2022 | -14.49 | -37.88% |
| 2021 | -23.32 | -47.41% |
| 2020 | -44.34 | N/A |
Comparison Keros Therapeutics (KROS) P/E with competitors
Keros Therapeutics (KROS) P/E is -3.17.